The troubles of Bharat Biotech’s US partner is bad news for India’s pharma industry

Two months before Ocugen, the US partner of Bharat Biotech International Ltd, announced its partnership with the company for bringing the covid-19 vaccine to the US, it was facing the threat of its shares being delisted from Nasdaq